J Seiderer
Sicherheit von anti-TNF-Antikörper-Therapien
Seiderer J, Brand S, Kaser A. Sicherheit von anti-TNF-Antikörper-Therapien. In: Zytokine und chronisch-entzündliche Darmerkrankungen - Pathogenese und Therapie. Bremen: Uni-Med-Verlag, 2009.
01.01.2009Sicherheit von anti-TNF-Antikörper-Therapien
01.01.2009Uni-Med-Verlag
Seiderer J, Brand Stephan, Kaser Arthur
The role of the selenoprotein S (SELS) gene -105G>A promoter polymorphism in inflammatory bowel disease and regulation of SELS gene expression in intestinal inflammation
Seiderer J, Lohse P, Ochsenkühn T, Göke B, Haller D, Török H, Konrad A, Pfennig S, Kühnlein B, Dambacher J, Brand S. The role of the selenoprotein S (SELS) gene -105G>A promoter polymorphism in inflammatory bowel disease and regulation of SELS gene expression in intestinal inflammation. Tissue Antigens 2007; 70:238-46.
01.09.2007The role of the selenoprotein S (SELS) gene -105G>A promoter polymorphism in inflammatory bowel disease and regulation of SELS gene expression in intestinal inflammation
01.09.2007Tissue Antigens 2007; 70:238-46
Seiderer J, Lohse P, Ochsenkühn T, Göke B, Haller D, Török H-P, Konrad A, Pfennig S, Kühnlein B, Dambacher J, Brand Stephan
Adalimumab in patients with Crohn's disease--safety and efficacy in an open-label single centre study
Seiderer J, Brand S, Dambacher J, Pfennig S, Jürgens M, Göke B, Ochsenkühn T. Adalimumab in patients with Crohn's disease--safety and efficacy in an open-label single centre study. Aliment Pharmacol Ther 2007; 25:787-96.
01.04.2007Adalimumab in patients with Crohn's disease--safety and efficacy in an open-label single centre study
01.04.2007Aliment Pharmacol Ther 2007; 25:787-96
Seiderer J, Brand Stephan, Dambacher J, Pfennig S, Jürgens M, Göke B, Ochsenkühn T
The +1059G/C polymorphism in the C-reactive protein (CRP) gene is associated with involvement of the terminal ileum and decreased serum CRP levels in patients with Crohn's disease
Thalmaier D, Lohse P, Ochsenkühn T, Göke B, Crispin A, Otte J, Pfennig S, Schachinger V, Konrad A, Seiderer J, Dambacher J, Brand S. The +1059G/C polymorphism in the C-reactive protein (CRP) gene is associated with involvement of the terminal ileum and decreased serum CRP levels in patients with Crohn's disease. Aliment Pharmacol Ther 2006; 24:1105-15.
01.10.2006The +1059G/C polymorphism in the C-reactive protein (CRP) gene is associated with involvement of the terminal ileum and decreased serum CRP levels in patients with Crohn's disease
01.10.2006Aliment Pharmacol Ther 2006; 24:1105-15
Thalmaier D, Lohse P, Ochsenkühn T, Göke B, Crispin A, Otte J-M, Pfennig S, Schachinger V, Konrad A, Seiderer J, Dambacher J, Brand Stephan
Infliximab zur Therapie chronisch entzündlicher Darmerkrankungen
Seiderer J, Schnitzler F, Brand S, Tillack C, Göke B, Ochsenkühn T. Infliximab zur Therapie chronisch entzündlicher Darmerkrankungen. Dtsch Arztebl 2005; 102:828-833.
04.10.2005Infliximab zur Therapie chronisch entzündlicher Darmerkrankungen
04.10.2005Dtsch Arztebl 2005; 102:828-833
Seiderer J, Schnitzler F, Brand Stephan, Tillack C, Göke B, Ochsenkühn T
Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease
Török H, Brünnler G, Jagiello P, Epplen J, Griga T, Klein W, Schiemann U, Folwaczny M, Ochsenkühn T, Brand S, Tillack C, Glas J, Tonenchi L, Lohse P, Müller-Myhsok B, Limbersky O, Neugebauer C, Schnitzler F, Seiderer J, Folwaczny C. Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease. Gut 2005; 54:1421-7.
14.06.2005Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease
14.06.2005Gut 2005; 54:1421-7
Török H-P, Brünnler G, Jagiello P, Epplen J T, Griga T, Klein W, Schiemann U, Folwaczny M, Ochsenkühn T, Brand Stephan, Tillack C, Glas J, Tonenchi L, Lohse P, Müller-Myhsok B, Limbersky O, Neugebauer C, Schnitzler F, Seiderer J, Folwaczny C